Most Popular
-
1
Chuseok still is a headache for couples
-
2
Lime green plates deepen slump in Korea’s luxury car sales
-
3
Yoon's approval rating hits new low: poll
-
4
Students suffer sleep deprivation, fatigue, suicidal thoughts
-
5
N. Korea launches trash balloons toward S. Korea for 2nd day: JCS
-
6
Heat wave watch issued for Seoul; latest on record
-
7
[AtoZ into Korean mind] Koreans do things quickly. Is it efficiency or lack of patience?
-
8
Calories that stalk the Chuseok table
-
9
Popular tourist destinations beckon Chuseok holidaymakers
-
10
Nearly 2,000 aging separated family members die in first 8 months of year: gov't data
-
Globe, Eastern Communications, InfiniVAN kickstart Philippines' longest submarine fiber cable network
MANILA, Philippine, Aug. 15, 2022 /PRNewswire/ -- Leading Philippine digital solutions platform Globe, premier telecommunications and ICT solutions provider Eastern Communications, and growing telecommunications and digital solutions provider InfiniVAN marked a milestone on Thursday, July 14, as they kickstarted the deployment of fiber cables to build the country's longest submarine fiber cable network. The $150-million Philippine Domestic Submarine Cable Network (PDSCN), a joint project
Aug. 15, 2022
-
Top Philippine fintech GCash boosts users to 66 million
GCash CEO says collaboration, not competition, key to exponential growth and financial inclusion MANILA, Philippines, Aug. 15, 2022 /PRNewswire/ -- As digital payments rapidly become a staple for many Filipinos, GCash, the leading mobile wallet in the Philippines and the country's first ever double unicorn has achieved yet another milestone as it grows its number of registered users to 66 million as of June 2022. This was one of the key highlights shared by the GCash president and CEO M
Aug. 15, 2022
-
Affinidi and Avvanz Sign MOU to Streamline Employment Background Checks in Singapore
SINGAPORE, Aug. 15, 2022 /PRNewswire/ -- Affinidi, a decentralised identity solutions provider founded by global investment company Temasek, today announced the signing of a Memorandum of Understanding ("MOU") with Avvanz to jointly establish and issue verifiable credentials ("VCs"), an open standard for tamper-evident digital credentials, to help simplify employment background checks for employers and job candidates in Singapore and the rest of the globe. The partnershi
Aug. 15, 2022
-
Yili Remains the World's Most Valuable Dairy Brand in Brand Finance 2022 Report
HUHHOT, China, Aug. 13, 2022 /PRNewswire/ -- On August 10, Brand Finance, the world's leading brand valuation and strategy consultancy, issued its Food & Drink 2022 report, identifying the most valuable and strongest brands in the food and beverage industries. Yili has been recognized as the World's Most Valuable Dairy Brand, retaining its leading position in the global dairy industry. A company's brand is among the most valuable intangible assets it holds. While the Covid-19 pandemic has
Aug. 13, 2022
-
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17
Novavax and partner SK bioscience will provide the first protein-based COVID-19 vaccine approved for use in adolescents aged 12 through 17 years in South Korea GAITHERSBURG, Md., Aug. 12, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that partner, SK bioscience, has received a Post Approval Change Application approval from the Korean Ministry
Aug. 12, 2022
-
Lunit Announces Financial Results for the First Half of 2022
Consolidated revenue in the second quarter of 2022 increased by 190% compared to same prior-year period Total revenue for H1 2022 amounted to KRW 5.48 billion, or 82.5% of the total revenue of last year SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- Lunit (KRX: 328130.KQ), a global provider of AI-powered cancer solutions, today announced strong financial results for the second quarter of the fiscal year 2022. "Through a strong overseas performance in the first
Aug. 12, 2022
-
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud
- Medical platform that converges Cloud, AI, and 3D bioprinting expected to dramatically improve treatment rate and medical access. SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- ROKIT Healthcare, a company specializing in bio-healthcare, today announced it will provide a hyper-personalized medical platform that uses 3D bioprinting and AI technology built on Google Cloud, to innovate the treatment of osteoarthritis and diabetes feet (diabetic foot lesion ulcer). ROKIT Healthcare'
Aug. 12, 2022
-
Rio South Texas: At the Nexus of North American Freight Railways Reports COSTEP
MISSION, Texas, Aug. 12, 2022 /PRNewswire/ -- Rio South Texas, located at the heart of the North American supply chain, has always been hailed for its multimodality. Major U.S-Mexico border crossings, international airports, deep-water seaports, and interstate highways have made the region the ultimate intermodal trade hub for businesses with North American operations. In addition, the region's connection to the North American Class 1 Rail Network is responsible for the export and import of hund
Aug. 12, 2022
-
Seegene reports H1 2022 financial results
H1 revenue fell 11% YoY to KRW 579.9 billion, operating profit down 37% to KRW 212.7 billion Decline due to drop in Q2 sales amid reduced PCR testing volume Sales of non-COVID products and PCR instruments increased in H1; Company launches STARlet-AIOS to strengthen sales foundation Seegene to expand In-life PCR campaign to help curb widespread COVID-19 transmissions and boost sales of non-COVID products to solidify revenue structure SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ --
Aug. 12, 2022
-
CATL announces its second European battery plant in Hungary
NINGDE, China, Aug. 12, 2022 /PRNewswire/ -- On August 12, 2022, Contemporary Amperex Technology Co., Limited (CATL) officially announced it will invest 7.34 billion euros to build a 100 GWh battery plant in Debrecen of east Hungary, which is also its second battery plant in Europe following its German plant. Subject to the shareholder meeting approval, construction of the first production facilities will start within this year. Conference Venue in Hungary Conference Venu
Aug. 12, 2022
-
UTM Vice-Chancellor' Message to the World: Work In-Silo No More, Upgrade Skills, Take Action
JOHOR BAHRU, Malaysia, Aug. 12, 2022 /PRNewswire/ -- The Vice-Chancellor of Universiti Teknologi Malaysia (UTM), Professor Datuk Ts Dr Ahmad Fauzi Ismail was invited by the Government of Australia to speak at the World Energy Forum in Sydney, Australia, held from 12th July to 14th July 2022. He was speaking as one of the panel speakers for the session on 'Workforce and Skills'. Work In-Silo No More, Upgrade Skills, Take Action The Australian government extended the invitation to Profe
Aug. 12, 2022
-
GWM HAVAL DARGO Unveiled in South America, Igniting Passion for Diversified Driving
BAODING, China, Aug. 12, 2022 /PRNewswire/ -- Recently, GWM HAVAL DARGO was launched in Chile and Peru in South America, bringing a brand-new driving experience to local customers. GWM HAVAL DARGO Unveiled in South America, Igniting Passion for Diversified Driving To let locals have a more real feeling of this car's power, the GWM held a long-distance test drive for HAVAL DARGO in Chile. The test drive models are all-wheel-drive edition, combining coziness of urban SUVs and driving pe
Aug. 12, 2022
-
"BUILDING LIVES" Return Visit to Affordable Housing Project in Algeria
Home with Love CARIO, Aug. 12, 2022 /PRNewswire/ -- In the new town of Sidi Abdellah in Algiers, there are some red-brown and beige buildings of its Mahelma community. In the evening, some residents walk leisurely on the paths, and groups of children happily playing near the slides. Many young people run on the football field, enjoying the game. This is the apartment complex of the Sidi Abdellah government subsidized housing built by China State Construction Engineering Cor
Aug. 12, 2022
-
International Youth Day 2022: XCMG Apprentice Season 7 Brings Insights and Opportunities of Construction Machinery Industry
XUZHOU, China, Aug. 12, 2022 /PRNewswire/ -- Themed with "Time Travelers," the seventh season of XCMG's (SHE:000425) immersive experience and innovative education program, XCMG Apprentice, was held in five countries for the first time. Young talents from China (Team Globe), Germany (Team Europe), Brazil (Team America), Thailand (Team Southeast Asia), and India (Team South Asia) joined the program to learn about XCMG as well as its people, products, technologies, industries and val
Aug. 12, 2022
-
Golden Bull Awards Marks Its 20th Anniversary
200 Malaysian businesses win iconic award as economy recovers KUALA LUMPUR, Malaysia, Aug. 12, 2022 /PRNewswire/ -- 2022 marks the 20th Golden Bull Award. Since its inception in 2003, the Golden Bull Award has gone on to recognize over 2,000 Malaysian businesses with about 17,000 nominees participating in the program. A proudly Malaysian brand, the Golden Bull Award has since expanded to, and organised in, Singapore, Taiwan and mainland China - helping bridge businesses across the region.
Aug. 12, 2022
-
SME CEO Forum Helps SMEs Navigate Through Economic Uncertainties
KUALA LUMPUR, Malaysia, Aug. 12, 2022 /PRNewswire/ -- Over 98.5 percent of all businesses in Malaysia are SMEs. Hailed variously as unsung heroes, backbone of the economy and even as employers of last resort, the importance of SMEs to the country's economy cannot be overstated. Yet, in 2021, SMEs only grew by 1% versus 4.4% among larger companies. This is underscored by a miniscule growth in labour productivity among SMEs of a mere 0.1% in 2021, or 6.4% lower than 2019. This shows that de
Aug. 12, 2022
-
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma.
SEOUL, South Korea, Aug. 12, 2022 /PRNewswire/ -- J INTS BIO announced that the pre-clinical data of its novel, orally administered 4th generation EGFR TKI 'JIN-A02' was presented at the 2022 IASLC World Conference on Lung Cancer in Vienna, Austria on 8th August, at the official session "Overcoming Resistance to EGFR Inhibitors". J INTS BIO CI In addition, the abstract no. MA07.08 entitled "JIN-A02, a Highly Effective 4th Generation EGFR-TKI, Targeting EGFR C797S Mu
Aug. 12, 2022
-
Science and Technology Daily: 5G Empowers International Communication Capacity in Multimedia Era
HARBIN, China, Aug. 11, 2022 /PRNewswire/ -- This is a report from Science and Technology Daily: 2022 is a crucial year for the large-scale development of 5G applications and the comprehensive iterative upgrading of the technology. Held both online and offline on August 9, the theme of the 2022 World 5G Convention Media Forum is "5G empowers international communication capacity". Experts and professionals from domestic and international media outlets, and 5G tech enterprises jointl
Aug. 12, 2022
-
SKYPlay opens pre-registration for Coin Grid prior to the platform's debut
SEOUL, South Korea, Aug. 11, 2022 /PRNewswire/ -- On August 11th, 2022, SKYPlay Inc. opens global pre-registration of Coin Grid, an eP2E(easy play-to-earn) game before the beta release of its blockchain platform, "SKYPlay" at the end of this month. All pre-registered participants will receive commodities and game characters which can be used in the game, Coin Grid. There will be an air-drop event for additional goodies, such as SKP tokens to those participants who take part in f
Aug. 11, 2022
-
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast cancer Submission supported by results from the pivotal Phase 3 EMERALD study of elacestrant showing statistically significant efficacy over current standard-of-care (SOC) medications for both the overall study population and patients whose tumors harbor an ESR1 mutation U.S. FDA has assigned a Prescript
Aug. 11, 2022